Case report | Volume 36, Article 116, 23 Jun 2020 | 10.11604/pamj.2020.36.116.22218

Rapidly progressive necrotizing pneumonia: remember the Streptococcus anginosus group!

Biplab Kumar Saha

Corresponding author: Biplab Kumar Saha, Ozarks Medical Center, West Plains, Missouri, United States of America

Received: 07 Mar 2020 - Accepted: 27 Mar 2020 - Published: 23 Jun 2020

Domain: Intensive care medicine,Internal medicine,Pulmonology

Keywords: Necrotizing pneumonia, lung abscess, pyopneumothorax, Streptococcus anginosus group

©Biplab Kumar Saha et al. Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Cite this article: Biplab Kumar Saha et al. Rapidly progressive necrotizing pneumonia: remember the Streptococcus anginosus group!. Pan African Medical Journal. 2020;36:116. [doi: 10.11604/pamj.2020.36.116.22218]

Available online at: https://www.panafrican-med-journal.com/content/article/36/116/full

Home | Volume 36 | Article number 116

Case report

Rapidly progressive necrotizing pneumonia: remember the Streptococcus anginosus group!

Rapidly progressive necrotizing pneumonia: remember the Streptococcus anginosus group!

Biplab Kumar Saha1,&

 

1Ozarks Medical Center, West Plains, Missouri, United States of America

 

 

&Corresponding author
Biplab Kumar Saha, Ozarks Medical Center, West Plains, Missouri, United States of America

 

 

Abstract

Acute necrotizing pneumonia in an immunocompetent host is uncommon and usually caused by Staphylococcus aureus infection. Streptococcus anginosus group (SAG) is a less recognized cause of rapidly destructive lung infection resulting in significant patient morbidity and mortality. Unlike many other bacterial infections, SAG can cross fascial planes and cause fulminant infections. Necrotizing pneumonia and lung abscesses due to SAG often fails conservative therapy with antimicrobials and requires definitive surgical intervention. Consideration of SAG as a potential etiology might help to institute definitive therapy earlier and prevent complications.

 

 

Introduction    Down

Acute necrotizing pneumonia in an immunocompetent host is an uncommon complication of bacterial pneumonia. Most cases of community-acquired necrotizing pneumonia are secondary to Staphylococcus infection, especially in patients who have suffered or are suffering from influenza or parainfluenza infection. Although reported in the literature, the streptococcus anginosus group (SAG) is not often considered in the differential diagnosis of necrotizing parenchymal lung infection. SAG is a normal flora of the oral cavity and is comprised of 3 distinct species: S. anginosus, S. constellatus and S. imdermedius. Infection with these bacteria could be extremely aggressive with a rapid formation of lung abscess and or empyema. Due to their ability to cross the fascial plane, the infection could erode through the chest wall or spill into the mediastinum resulting in fulminant mediastinitis, sepsis, and shock state. In contrast to an abscess in other bodily organs, lung abscess, historically is not drained by surgical or percutaneous interventions. As the communication of the abscess cavity with the airway results in ‘auto drainage’ of the abscess, a drainage procedure is considered unnecessary or potentially dangerous. Long-term antibiotic therapy with anaerobic coverage is the standard of care. However, in patients who develop lung abscess or empyema due to SAG infection, drainage and possibly surgical resection is essential in addition to the antimicrobial therapy for resolution of the infection. Delay in timely care could be life-threatening and causes significant morbidity.

 

 

Patient and observation Up    Down

A 45-year old male presented to the ED with mild fever, sneezing, rhinorrhea, cough, right-sided dull chest pain and shortness of breath. He was recently exposed to a co-worker suffering from ‘flu’ and started experiencing upper respiratory tract infection symptoms two days ago. He was nauseous, vomited several times and suffered from diarrhea. The persistent dull chest pain and worsening exertional shortness of breath for a day prompted the ED visit. His past medical history was significant for Crohn´s disease for which he was not on any medication. The patient was a smoker of about half a pack per day and denied any history of alcohol or recreational drug abuse. He traveled to South Africa twenty-three years ago and didn´t have any pet at home. No personal history of tuberculosis (TB) or known exposure to anyone with TB. He worked at a fast-food restaurant and did not have any family history of vasculitis or lung cancer. Vital signs on admission were, a blood pressure of 135/89 mmHg, a pulse of 124 beats per minutes, a temperature of 37.8°C, a respiratory rate of 23 breaths per minute and oxygen saturation of 94% on 5L oxygen via nasal cannula. Physical examination showed a young man in mild distress from tachypnea.

 

He appeared dehydrated. Chest auscultation revealed bronchial breath sound and coarse crackles in the right mid and lower lung zone, both anteriorly and posteriorly. The rest of the examination was normal. Blood work was significant for leukocytosis, 27.1 x103/micro L with neutrophilia of 88% and bandemia of 3%. The rest of the complete blood count and comprehensive metabolic panel were normal. His lactic acid was 1.5mmol/L, and procalcitonin level was elevated at 0.69ng/ml. The chest X-ray is shown in Figure 1. A computed tomography (CT) of the chest was performed and representative slices are shown in Figure 1. The respiratory viral panel was positive for coronavirus. Sputum gram stain and culture showed normal respiratory flora. Urinary antigen testing for legionella and pneumococcus were negative. A workup for vasculitic disorders was negative. HIV antibody test was also negative. A diagnosis of necrotizing pneumonia due to secondary bacterial infection in the setting of coronavirus infection was made. Staphylococcus aureus (SA) was strongly suspected to be the etiologic agent. However, the patient was less toxic appearing than what would be expected with SA necrotizing pneumonia and a subacute vasculitic disorder, like granulomatosis with polyangiitis, was also considered.

 

Cavitary pneumonia with a fungal pathogen and lung malignancy were other possibilities, but no significant risk factors, such as prolonged neutropenia, chronic steroid use or prior structural lung disease were present. The patient was started on linezolid and meropenem. High-flow oxygen was used to achieve acceptable oxygen saturation level. Repeat chest X-rays on day one, two and three are shown in Figure 2. A repeat CT scan was obtained on day three to identify the structural lung damage better (Figure 3). He developed progressive respiratory failure requiring intubation and mechanical ventilation. An ultrasound revealed complex pleural effusion (Figure 4). A chest tube was inserted and 1.4L of frank pus was drained. A large air leak was noted from bronchopleural fistula (BPF) due to rupture of the abscess cavity in the pleural space. Pleural fluid analysis showed 457,000 leukocyte per cubic milliliter with 99% neutrophil, pH 6.9, glucose < 10mg/dL, protein 4.3gm/dL and lactate dehydrogenase > 10,000 IU/L. The culture was positive for SAG, species S constellatus. The patient was treated with ceftriaxone with subsequent improvement. He got liberated from mechanical ventilation. The BPF resolved, and the chest tube was successfully removed (Figure 5). He was completely functional during his outpatient visit a month later.

 

 

Discussion Up    Down

Rapidly evolving necrotizing pneumonia (NP) complicated by lung abscess and empyema formation is a rare complication of community-acquired bacterial pneumonia. Even though it is rare, the disease progression can be extremely rapid with the virtual destruction of the lung parenchyma in a matter of days. In most reported cases, Panton-Valentine leukocidin (PVL) toxin-producing S. aureus (both methicillin sensitive and resistant SA) was found to be the culprit organism [1-3]. The incidence of community-acquired pneumonia (CAP) due to SA is only about 1.6% among all cases of CAP [4]. However, necrotizing pneumonia, especially in the setting of co or prior influenza infection is predominantly due to superimposed SA infection. Viruses other than influenza, such as rhinovirus and respiratory syncytial virus have been shown to increase upper airway colonization by SA transiently, but whether these viruses make the patient more susceptible to SA pneumonia, is unclear [5]. The other reported bacteria include Streptococcus pneumoniae, Klebsiella pneumoniae, group A Streptococcus and Pseudomonas aeruginosa [6-9]. In clinical practice, patients from the community who present with NP, SA infection is almost universally considered to be the likely etiology.

 

SAG is part of the human oral and gastrointestinal tract microflora and an unusual pathogen for NP. Identification of members of SAG as the causative organism carries important clinical implications. SAG has been implicated in the causation of a broad spectrum of infections. Members of SAG are often associated with pharyngitis and endodontic infections [10]. Suppurative infection, either local or distant, is a common complication. Local suppurative infection in the form of head and neck abscess, jugular vein thrombophlebitis [11], peritonsillar abscess [12] and cervical necrotizing fasciitis [13], have been described. SAG bacteremia in the absence of any apparent infection has also been reported [14]. Identification of SAG bacteremia should prompt a workup for metastatic abscesses [15]. In contrast to NP, due to SA, patients with SAG pneumonia appear less toxic, at least on presentation. Very high fever is usually uncommon [16]. Risk factors include male sex, alcoholism, cancer and cystic fibrosis. Our patient had a co-existent coronavirus infection. Whether that played a role in the pathogenesis of the disease is uncertain. SAG causes invasive lung infection either alone or as a part of polymicrobial infection, including oral anaerobes. Aspiration of oropharyngeal content is the likely inciting event.

 

Necrotizing pneumonia, lung abscess, empyema, mediastinitis resulting in septic shock and death have been reported [17,18]. SAG has the unique ability to extend beyond fascial planes and has been reported to cross interlobar fissures, diaphragm or even erode through the chest wall [19] and should be considered as a potential etiology in such situations. Management of thoracic infection due to SAG is quite different from the norm. In general, there is no established surgical guideline regarding the management of acute bacterial necrotizing pneumonia. Surgical intervention is usually considered in the setting of septic shock as a source control measure [20]. Lung abscesses that develop from necrotizing pneumonia, communicate with an airway and undergo auto-drainage and usually only require long term antibiotic therapy. But due to the SAG´s ability to cross fascial planes, the lung abscess is often complicated by empyema due to rupture of the abscess in the pleural cavity. In one study, 67% of patients failed antibiotic therapy and required surgical intervention for definitive management [21]. The progression of the disease could be explosive, as was in this case. Four weeks of an intravenous antibiotic such as ceftriaxone with anaerobic coverage or a combination of beta-lactam and a beta-lactamase inhibitor, in addition to surgical intervention is considered optimal therapy.

 

 

Conclusion Up    Down

Necrotizing pneumonia in the modern era of antibiotic is a rare event. Most common causes include SA or a pneumococcal lung infection. Invasive lung infection due to SAG is a known but underappreciated etiology. SAG should be considered in patients with a fulminant necrotizing lung infection in the presence of risk factors as well as evidence of extension beyond fascial planes. Treatment with antibiotic therapy often fails and surgical intervention should be considered early in the disease process as a delay in therapy could result in significant morbidity and mortality.

 

 

Competing interests Up    Down

The author declares no competing interests.

 

 

Authors' contributions Up    Down

BKS was involved in direct patient care, planned, collected data and prepared the manuscript. He has read and agreed to the final manuscript.

 

 

Figures Up    Down

Figure 1: A) chest X-ray on admission showing focal infiltrate in the right midlung zone involving the minor fissure with multiple areas of lucencies suggestive of abscess formation; B) computed tomography (CT) axial view demonstrating dense consolidation of the right middle lobe (RML) and abscess with air-fluid level; C) coronal CT with revealing RML necrotizing pneumonia as well as thick wall cavity in the right lower lobe (RLL); D) C) sagittal view with RML and RLL necrotizing pneumonia and abscess formation

Figure 2: A) day 1 post-admission chest X-rays showing the development of large fluid-filled cavities; B) day 2 post-admission chest X-rays showing the development of large fluid-filled cavities; C) reduction in the airspace in the right hemithorax (day 3)

Figure 3: A) coronal chest CT on day 3 showing a significant increase in the size of the abscess cavity and dense consolidation in RLL; B) sagittal chest CT on day 3 showing a significant increase in the size of the abscess cavity and dense consolidation in RLL

Figure 4: bedside ultrasound showing complex pleural effusion with cellularity (brown arrow), septations (yellow arrow) and atelectatic lung (black arrow). The diaphragm (indigo arrow), liver (red arrow), chest wall (lime arrow) are also visible

Figure 5: chest X-ray after drainage with a chest tube demonstrated significant improvement in lung aeration with residual pleural and basilar lung changes

 

 

References Up    Down

  1. Tsai YF, Ku YH. Necrotizing pneumonia: a rare complication of pneumonia requiring special consideration. Current Opinion in Pulmonary Medicine. 2012;18(3):246-52. PubMed | Google Scholar

  2. Chetchotisakd P, Anunnatsiri S, Puapermpoonsiri S, Prariyachatgul C, Chumpol J. A rapidly fatal case of Panton-valentine leukocidin positive Staphylococcus aureus necrotizing pneumonia in an HIV-infected patient. The Southeast Asian Journal of Tropical Medicine and Public Health. 2007;38(4):690-4. PubMed | Google Scholar

  3. Saha B, Fless K, Yodice P, Ovnanian V, Rezai F, Mistry N. The case of the vanishing lung. CHEST. 2016;150(4):402A. Google Scholar

  4. Self WH, Wunderink RG, Williams DJ, Zhu Y, Anderson EJ, Balk RA et al. Staphylococcus aureus community-acquired pneumonia: prevalence, clinical characteristics and outcomes. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2016;63(3):300-9. PubMed | Google Scholar

  5. Morgene MF, Botelho-Nevers E, Grattard F, Pillet S, Berthelot P, Pozzetto B et al. Staphylococcus aureus colonization and non-influenza respiratory viruses: interactions and synergism mechanisms. Virulence. 2018;9(1):1354-63. PubMed | Google Scholar

  6. Bender JM, Ampofo K, Korgenski K, Daly J, Pavia AT, Mason EO et al. Pneumococcal necrotizing pneumonia in Utah: does serotype matter. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2008;46(9):1346-52. PubMed | Google Scholar

  7. Okada F, Ando Y, Honda K, Nakayama T, Ono A, Tanoue S et al. Acute Klebsiella pneumoniae alone and with concurrent infection: comparison of clinical and thin-section CT findings. The British journal of radiology. 2010;83(994):854-60. PubMed | Google Scholar

  8. Crnich CJ, Gordon B, Andes D. Hot tub-associated necrotizing pneumonia due to Pseudomonas aeruginosa. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2003;36(3):e55-7. PubMed | Google Scholar

  9. Cengiz AB, Kanra G, Caglar M, Kara A, Gucer S, Ince T. Fatal necrotizing pneumonia caused by group A streptococcus. Journal of Paediatrics and Child Health. 2004;40(1-2):69-71. PubMed | Google Scholar

  10. Drucker DB, Green RM. Dental caries induced by Streptococcus milleri. Journal of Dental Research. 1977;56(9):1062. PubMed | Google Scholar

  11. Noy D, Rachmiel A, Levy-Faber D, Emodi O. Lemierre's syndrome from odontogenic infection: review of the literature and case description. Annals of Maxillofacial Surgery. 2015;5(2):219-25. PubMed | Google Scholar

  12. Wiksten J, Kaltiainen E, Pitkaranta A, Blomgren K. Renewal of peritonsillar abscess: impact of the bacterial species of the infection and clinical features of the patient- a prospective comparative aetiological study. Clinical Otolaryngology. 2017;42(6):1358-62. PubMed | Google Scholar

  13. Elander J, Nekludov M, Larsson A, Nordlander B, Eksborg S, Hydman J. Cervical necrotizing fasciitis: descriptive, retrospective analysis of 59 cases treated at a single center. European Archives of Oto-rhino-laryngology. 2016;273(12):4461-7. PubMed | Google Scholar

  14. Bert F, Bariou-Lancelin M, Lambert-Zechovsky N. Clinical significance of bacteremia involving the "Streptococcus milleri" group: 51 cases and review. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 1998;27(2):385-7. PubMed | Google Scholar

  15. Suzuki H, Hase R, Otsuka Y, Hosokawa N. Bloodstream infections caused by Streptococcus anginosus group bacteria: a retrospective analysis of 78 cases at a Japanese tertiary hospital. Journal of Infection and Chemotherapy. 2016;22(7):456-60. PubMed | Google Scholar

  16. Wong CA, Donald F, Macfarlane JT. Streptococcus milleri pulmonary disease: a review and clinical description of 25 patients. Thorax. 1995;50(10):1093-6. PubMed | Google Scholar

  17. Che Rahim MJ, Mohammad N, Wan Ghazali WS. Pyopneumothorax secondary to Streptococcus milleri infection. BMJ case reports. 2016;2016:bcr2016217537. PubMed | Google Scholar

  18. Porta G, Rodriguez-Carballeira M, Gomez L, Salavert M, Freixas N, Xercavins M et al. Thoracic infection caused by Streptococcus milleri. The European respiratory journal. 1998;12(2):357-62. PubMed | Google Scholar

  19. Sunwoo BY, Miller WT Jr. Streptococcus anginosus infections: crossing tissue planes. Chest. 2014;146(4):e121-e5. PubMed | Google Scholar

  20. Reimel BA, Krishnadasen B, Cuschieri J, Klein MB, Gross J, Karmy-Jones R. Surgical management of acute necrotizing lung infections. Canadian respiratory journal. 2006;13(7):369-73. PubMed | Google Scholar

  21. Ripley RT, Cothren CC, Moore EE, Long J, Johnson JL, Haenel JB. Streptococcus milleri infections of the pleural space: operative management predominates. American journal of surgery. 2006;192(6):817-21. PubMed | Google Scholar

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Case report

Rapidly progressive necrotizing pneumonia: remember the Streptococcus anginosus group!

Case report

Rapidly progressive necrotizing pneumonia: remember the Streptococcus anginosus group!

Case report

Rapidly progressive necrotizing pneumonia: remember the Streptococcus anginosus group!

Volume 36 (May - Aug 2020)
This article authors
On Pubmed
On Google Scholar
Citation [Download]
EndNote
Reference Manager
Zotero
BibTex
ProCite

Navigate this article
Key words

Necrotizing pneumonia

Lung abscess

Pyopneumothorax

Streptococcus anginosus group

PlumX Metrics
Rapidly progressive necrotizing pneumonia: remember the Streptococcus anginosus group!